# Evaluation of Preoperative N1539 in Total Knee Arthroplasty

> **NCT03434275** · PHASE3 · COMPLETED · sponsor: **Baudax Bio** · enrollment: 194 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** N1539
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03434275
- **Lead sponsor:** Baudax Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-19
- **Primary completion:** 2019-05-21
- **Final completion:** 2019-05-21
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2023-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03434275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03434275, "Evaluation of Preoperative N1539 in Total Knee Arthroplasty". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03434275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*